Multidrug-resistant tuberculosis in Australia, 1998–2012
DESIGN: A retrospective review was undertaken involving all patients with laboratory-confirmed MDR-TB notified in Australia between 1998 and 2012 inclusive. Demographic, clinical and laboratory features are described. Clinical outcomes were defined according to World Health Organization definitions of treatment success (cure and treatment completion), treatment failure, death, loss to follow-up (including transfer out), or not evaluated at treatment completion.
RESULTS: A total of 244 cases of MDR-TB were diagnosed in Australia during the study period, representing 1.4% of all TB cases notified. The majority were born outside Australia, including one third in Papua New Guinea. Of those with treatment outcome data available, treatment success was demonstrated in 81%. Treatment success was positively associated with use of a second-line injectable agent. Those born in Papua New Guinea were less likely to achieve treatment success.
CONCLUSION: MDR-TB is uncommon in Australia. The large number of cases born in Papua New Guinea, and the poorer outcomes in this cohort, represent challenges with cross-border management of MDR-TB in the Torres Strait. Australia has an ongoing role in the prevention and management of MDR-TB locally and in the region.
Keywords: Australia; MDR-TB; TB; epidemiology
Document Type: Research Article
Affiliations: 1: Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Department of Paediatrics, Royal Darwin Hospital, Darwin, Northern Territory 2: Department of Paediatrics, Royal Darwin Hospital, Darwin, Northern Territory 3: Department of Infectious Diseases, Princess Margaret Hospital for Children, Perth, Western Australia, Telethon Kids Institute, University of Western Australia, Perth, Western Australia 4: Victorian Tuberculosis Program, Melbourne Health, Melbourne, Victoria 5: New South Wales Tuberculosis Program, Sydney, New South Wales 6: Communicable Diseases Branch, Queensland Health, Brisbane, Queensland 7: South Australia Tuberculosis Services, Adelaide, South Australia 8: Northern Territory Centre for Disease Control, Darwin, Northern Territory 9: Western Australia Tuberculosis Control Centre, Perth, Western Australia, Australia
Publication date: 01 March 2018
The International Journal of Tuberculosis and Lung Disease (IJTLD) is for clinical research and epidemiological studies on lung health, including articles on TB, TB-HIV and respiratory diseases such as COVID-19, asthma, COPD, child lung health and the hazards of tobacco and air pollution. Individuals and institutes can subscribe to the IJTLD online or in print – simply email us at [email protected] for details.
The IJTLD is dedicated to understanding lung disease and to the dissemination of knowledge leading to better lung health. To allow us to share scientific research as rapidly as possible, the IJTLD is fast-tracking the publication of certain articles as preprints prior to their publication. Read fast-track articles.
- Editorial Board
- Information for Authors
- Subscribe to this Title
- International Journal of Tuberculosis and Lung Disease
- Public Health Action
- Ingenta Connect is not responsible for the content or availability of external websites
- Access Key
- Free content
- Partial Free content
- New content
- Open access content
- Partial Open access content
- Subscribed content
- Partial Subscribed content
- Free trial content